secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001558370-24-000683
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q2 organic revenue down 2% to $272.6M; GAAP EPS $0.17 vs $0.31 YoY; declares $0.08 dividend
--------------------------------------------------------------------------------

- Q2 organic revenue declined 2% to $272.6M; reported revenue flat vs prior year.
- GAAP EPS $0.17 vs $0.31 YoY; adjusted EPS $0.40 vs $0.47.
- Cash flow from operations $142.5M, up 18% YoY.
- Board declared $0.08 per share quarterly dividend, payable Feb 26, 2024.
- Dr. Matthew F. McManus appointed President of Diagnostics and Genomics segment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837024000683/0001558370-24-000683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837024000683/tmb-20240201x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer